How Fast Should We Post a Vaccine to Market? Dr. Robert Califf explained the pros and cons of an Emergency Use Authorization
Flu and COVID: Why Public Trust in Vaccines is So Critical Trio of Duke experts address threat of a 'twindemic' and development of a COVID vaccine Not sure whether to get a flu shot this year? The flu has similar symptoms to COVID-19,...
Better, Faster Research on Emerging Infectious Diseases Duke, RTI to partner on new federally funded center
Meet the Team Powering Duke’s COVID-19 Surveillance Testing Efforts Students returning to Duke University are participating in surveillance testing to help rapidly...
Pool Testing: How Does It Work? Duke’s comprehensive COVID-19 testing protocol includes "pooled" community...
Duke to Start Trial of Promising COVID Antibody Treatment If treatment is effective, it would advance COVID care until vaccine is developed The Duke Human Vaccine Institute (DHVI) has been given approval to launch a Phase 1 clinical...
Duke Labs Begin Phased, Deliberate March Toward Reopening With plenty of safeguards and patience, some research resumes in pockets on campus On most days, Stacy Horner does her work in the CARL Building, where corridors and labs are...
